VYALEV
Google image searchProduct monograph
Active ingredients
foslevodopa, 240 MG/ML
foscarbidopa, 12 MG/ML
DIN: 02537702
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Schedule: Prescription
Company: ABBVIE CORPORATION
Date: 05-FEB-2024
ATC:
- N04 — ANTI-PARKINSON DRUGS (ATC, ATC/DDD, )
- N04B — DOPAMINERGIC AGENTS (ATC, ATC/DDD)
- N04BA — Dopa and dopa derivatives (ATC, ATC/DDD)
- N04BA07 — FOSLEVODOPA AND DECARBOXYLASE INHIBITOR (ATC/DDD)
